Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantification of Amino Acid and Glucose Metabolism in Healthy Controls and NAFLD Patients Using Total-Body PET
NCT07366710Active, not recruiting
- Sponsor
- Rigshospitalet
- Start
- Nov 2024
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label trial (4 arms), sponsored by Rigshospitalet. Primary endpoint: Whole-body tracer uptake. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT07366710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07366710.